TreeWAS – Variant ID: rs9918079

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z42.1 Follow-up care involving plastic surgery of breast	0.063	0.937	0.000
Z42 Follow-up care involving plastic surgery	0.026	0.974	0.000
N92.6 Irregular menstruation, unspecified	0.000	0.974	0.026
Z42.3 Follow-up care involving plastic surgery of upper extremity	0.025	0.975	0.000
Z42.8 Follow-up care involving plastic surgery of other body part	0.019	0.981	0.000
Z42.4 Follow-up care involving plastic surgery of lower extremity	0.019	0.981	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.018	0.982	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.016	0.984	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.016	0.984	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.016	0.984	0.000
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.015	0.985	0.000
Z42.9 Follow-up care involving plastic surgery, unspecified	0.015	0.985	0.000
T42.0 Hydantoin derivatives	0.015	0.985	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.014	0.986	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.014	0.986	0.000
Z42.0 Follow-up care involving plastic surgery of head and neck	0.014	0.986	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.013	0.987	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.013	0.987	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.012	0.987	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.013	0.987	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.012	0.988	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.012	0.988	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.988	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.988	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.988	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.988	0.000
T44.0 Anticholinesterase agents	0.011	0.988	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.011	0.989	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.011	0.989	0.000
T42.4 Benzodiazepines	0.011	0.989	0.000
T42.1 Iminostilbenes	0.010	0.990	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.010	0.990	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
Z92.6 Personal history of chemotherapy for neoplastic disease	0.010	0.990	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.010	0.990	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.010	0.990	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.010	0.990	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.010	0.990	0.000
N19 Unspecified renal failure	0.000	0.990	0.010
T46.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.991	0.000
T38.7 Androgens and anabolic congeners	0.009	0.991	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T38.4 Oral contraceptives	0.009	0.991	0.000
T38.2 Antithyroid drugs	0.009	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.991	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.991	0.000
T36 Poisoning by systemic antibiotics	0.009	0.991	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.009	0.991	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.009	0.991	0.000
T46.7 Peripheral vasodilators	0.009	0.991	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.009	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.009	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.009	0.991	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.009	0.991	0.000
T38.1 Thyroid hormones and substitutes	0.009	0.991	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.009	0.991	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.008	0.991	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.008	0.991	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.008	0.991	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.008	0.991	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.008	0.991	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.008	0.991	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.008	0.992	0.000
T46.1 Calcium-channel blockers	0.008	0.992	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
T47.7 Emetics	0.008	0.992	0.000
T47.6 Antidiarrhoeal drugs	0.008	0.992	0.000
T47.5 Digestants	0.008	0.992	0.000
T47.4 Other laxatives	0.008	0.992	0.000
T47.3 Saline and osmotic laxatives	0.008	0.992	0.000
T47.2 Stimulant laxatives	0.008	0.992	0.000
T47.0 Histamine H(2)-receptor antagonists	0.008	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
T37.5 Antiviral drugs	0.007	0.993	0.000
T37.4 Anthelminthics	0.007	0.993	0.000
T37.3 Other antiprotozoal drugs	0.007	0.993	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
T37.1 Antimycobacterial drugs	0.007	0.993	0.000
T37.0 Sulphonamides	0.007	0.993	0.000
T41.5 Therapeutic gases	0.007	0.993	0.000
T41.4 Anaesthetic, unspecified	0.007	0.993	0.000
T41.3 Local anaesthetics	0.007	0.993	0.000
T41.2 Other and unspecified general anaesthetics	0.007	0.993	0.000
T41.1 Intravenous anaesthetics	0.007	0.993	0.000
T41.0 Inhaled anaesthetics	0.007	0.993	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.007	0.993	0.000
T48.5 Anti-common-cold drugs	0.007	0.993	0.000
T48.4 Expectorants	0.007	0.993	0.000
T48.3 Antitussives	0.007	0.993	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.007	0.993	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993	0.000
T48.0 Oxytocic drugs	0.007	0.993	0.000
T49.9 Topical agent, unspecified	0.007	0.993	0.000
T49.8 Other topical agents	0.007	0.993	0.000
T49.7 Dental drugs, topically applied	0.007	0.993	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.993	0.000
T49.5 Ophthalmological drugs and preparations	0.007	0.993	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
T49.3 Emollients, demulcents and protectants	0.007	0.993	0.000
T49.2 Local astringents and local detergents	0.007	0.993	0.000
T49.1 Antipruritics	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
T40.6 Other and unspecified narcotics	0.007	0.993	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.007	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
T36.8 Other systemic antibiotics	0.007	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.007	0.993	0.000
T36.6 Rifamycins	0.007	0.993	0.000
T36.5 Aminoglycosides	0.007	0.993	0.000
T36.4 Tetracyclines	0.007	0.993	0.000
T36.3 Macrolides	0.007	0.993	0.000
T36.2 Chloramphenicol group	0.007	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.993	0.000
T40.4 Other synthetic narcotics	0.007	0.993	0.000
W07.0 Home	0.007	0.993	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.006	0.993	0.000
T40.8 Lysergide [LSD]	0.006	0.993	0.000
T40.7 Cannabis (derivatives)	0.006	0.993	0.000
T40.5 Cocaine	0.006	0.993	0.000
T40.3 Methadone	0.006	0.993	0.000
T40.1 Heroin	0.006	0.993	0.000
T40.0 Opium	0.006	0.993	0.000
T50.8 Diagnostic agents	0.006	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
T50.5 Appetite depressants	0.006	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.006	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.006	0.994	0.000
M05 Seropositive rheumatoid arthritis	0.006	0.994	0.000
Y83.4 Other reconstructive surgery	0.006	0.994	0.000
T36.0 Penicillins	0.006	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
S22.30 Fracture of rib (closed)	0.006	0.994	0.000
D75.1 Secondary polycythaemia	0.000	0.994	0.006
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
M05.2 Rheumatoid vasculitis	0.005	0.995	0.000
M48.09 Spinal stenosis (Site unspecified)	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M05.8 Other seropositive rheumatoid arthritis	0.005	0.995	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.005	0.995	0.000
M05.1 Rheumatoid lung disease	0.005	0.995	0.000
M05.0 Felty's syndrome	0.005	0.995	0.000
M05.29 Rheumatoid vasculitis (Site unspecified)	0.004	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.995	0.000
C01 Malignant neoplasm of base of tongue	0.005	0.995	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
W07 Fall involving chair	0.004	0.996	0.000
M05.28 Rheumatoid vasculitis (Other)	0.004	0.996	0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.004	0.996	0.000
M05.26 Rheumatoid vasculitis (Lower leg)	0.004	0.996	0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.004	0.996	0.000
M05.24 Rheumatoid vasculitis (Hand)	0.004	0.996	0.000
M05.23 Rheumatoid vasculitis (Forearm)	0.004	0.996	0.000
M05.22 Rheumatoid vasculitis (Upper arm)	0.004	0.996	0.000
M05.21 Rheumatoid vasculitis (Shoulder region)	0.004	0.996	0.000
M05.20 Rheumatoid vasculitis (Multiple sites)	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
R51 Headache	0.000	0.996	0.004
I84.1 Internal haemorrhoids with other complications	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
W07.9 Unspecified place	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
M05.09 Felty's syndrome (Site unspecified)	0.003	0.996	0.000
M05.08 Felty's syndrome (Other)	0.003	0.996	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.003	0.996	0.000
M05.06 Felty's syndrome (Lower leg)	0.003	0.996	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.003	0.996	0.000
M05.04 Felty's syndrome (Hand)	0.003	0.996	0.000
M05.03 Felty's syndrome (Forearm)	0.003	0.996	0.000
M05.02 Felty's syndrome (Upper arm)	0.003	0.996	0.000
M05.01 Felty's syndrome (Shoulder region)	0.003	0.996	0.000
M05.00 Felty's syndrome (Multiple sites)	0.003	0.996	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.003	0.996	0.000
M05.18 Rheumatoid lung disease (Other)	0.003	0.996	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.003	0.996	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.003	0.996	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.003	0.996	0.000
M05.14 Rheumatoid lung disease (Hand)	0.003	0.996	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.003	0.996	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.003	0.996	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.003	0.996	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.003	0.996	0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.003	0.996	0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.003	0.996	0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.003	0.996	0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.003	0.996	0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.003	0.996	0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.003	0.996	0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.003	0.996	0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.003	0.996	0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.003	0.996	0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.003	0.996	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.003	0.996	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.003	0.996	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.003	0.996	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.003	0.996	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.003	0.996	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.003	0.996	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.003	0.996	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.003	0.996	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.003	0.996	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.003	0.996	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.004	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.996	0.000
A49.1 Streptococcal infection, unspecified	0.003	0.996	0.000
A49.0 Staphylococcal infection, unspecified	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
D25.1 Intramural leiomyoma of uterus	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
C02.9 Tongue, unspecified	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
W07.5 Trade and service area	0.003	0.997	0.000
W07.2 School, other institution and public administrative area	0.003	0.997	0.000
W07.8 Other specified place	0.003	0.997	0.000
W07.7 Farm	0.003	0.997	0.000
W07.6 Industrial and construction area	0.003	0.997	0.000
W07.4 Street and highway	0.003	0.997	0.000
W07.3 Sports and athletics area	0.003	0.997	0.000
W07.1 Residential institution	0.003	0.997	0.000
K90.9 Intestinal malabsorption, unspecified	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
L53.9 Erythematous condition, unspecified	0.003	0.997	0.000
C02.1 Border of tongue	0.003	0.997	0.000
M62.8 Other specified disorders of muscle	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
S22.3 Fracture of rib	0.003	0.997	0.000
X63.0 Home	0.003	0.997	0.000
M62.83 Other specified disorders of muscle (Forearm)	0.003	0.997	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.003	0.997	0.000
L73.9 Follicular disorder, unspecified	0.003	0.997	0.000
S82.30 Fracture of lower end of tibia (closed)	0.000	0.997	0.003
C20 Malignant neoplasm of rectum	0.003	0.997	0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.003	0.997	0.000
A49 Bacterial infection of unspecified site	0.003	0.997	0.000
C02.4 Lingual tonsil	0.003	0.997	0.000
C02.8 Overlapping lesion of tongue	0.002	0.997	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.997	0.000
C02.2 Ventral surface of tongue	0.002	0.997	0.000
C02.0 Dorsal surface of tongue	0.002	0.997	0.000
W07.29 Fall involving chair; School, other institution and public administrative area; During unspecified activity	0.002	0.997	0.000
L50.0 Allergic urticaria	0.003	0.997	0.000
C09 Malignant neoplasm of tonsil	0.002	0.997	0.000
M79.69 Pain in limb (Site unspecified)	0.003	0.997	0.000
L50.9 Urticaria, unspecified	0.003	0.997	0.000
M62.87 Other specified disorders of muscle (Ankle and foot)	0.002	0.997	0.000
M62.84 Other specified disorders of muscle (Hand)	0.002	0.997	0.000
I21.4 Acute subendocardial myocardial infarction	0.003	0.997	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.003	0.997	0.000
C05 Malignant neoplasm of palate	0.002	0.997	0.000
M62.82 Other specified disorders of muscle (Upper arm)	0.002	0.998	0.000
Q38.7 Pharyngeal pouch	0.002	0.998	0.000
L50 Urticaria	0.002	0.998	0.000
M62 Other disorders of muscle	0.002	0.998	0.000
M62.5 Muscle wasting and atrophy, not elsewhere classified	0.002	0.998	0.000
C13 Malignant neoplasm of hypopharynx	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
C04 Malignant neoplasm of floor of mouth	0.002	0.998	0.000
C00 Malignant neoplasm of lip	0.002	0.998	0.000
L53 Other erythematous conditions	0.002	0.998	0.000
S22.31 Fracture of rib (open)	0.002	0.998	0.000
C03 Malignant neoplasm of gum	0.002	0.998	0.000
D75 Other diseases of blood and blood-forming organs	0.000	0.998	0.002
L53.0 Toxic erythema	0.002	0.998	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.002	0.998	0.000
C09.9 Tonsil, unspecified	0.002	0.998	0.000
S01.9 Open wound of head, part unspecified	0.002	0.998	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.002	0.998	0.000
C05.1 Soft palate	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
Q89.2 Congenital malformations of other endocrine glands	0.002	0.998	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.002	0.998	0.000
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.002	0.998	0.000
V18.0 Driver injured in nontraffic accident	0.002	0.998	0.000
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
D75.2 Essential thrombocytosis	0.000	0.998	0.002
C11 Malignant neoplasm of nasopharynx	0.002	0.998	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.002	0.998	0.000
K14.9 Disease of tongue, unspecified	0.002	0.998	0.000
A49.3 Mycoplasma infection, unspecified	0.002	0.998	0.000
L50.1 Idiopathic urticaria	0.002	0.998	0.000
Z85.6 Personal history of leukaemia	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
M62.6 Muscle strain	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.002	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.002	0.998	0.000
I44.7 Left bundle-branch block, unspecified	0.000	0.998	0.002
Q63.0 Accessory kidney	0.002	0.998	0.000
C13.0 Postcricoid region	0.002	0.998	0.000
C09.8 Overlapping lesion of tonsil	0.002	0.998	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.002	0.998	0.000
C09.0 Tonsillar fossa	0.002	0.998	0.000
M62.0 Diastasis of muscle	0.002	0.998	0.000
Q89 Other congenital malformations, not elsewhere classified	0.002	0.998	0.000
C05.8 Overlapping lesion of palate	0.002	0.998	0.000
C05.2 Uvula	0.002	0.998	0.000
C05.0 Hard palate	0.002	0.998	0.000
C12 Malignant neoplasm of pyriform sinus	0.002	0.998	0.000
C00.0 External upper lip	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.002	0.998	0.000
C03.1 Lower gum	0.002	0.998	0.000
C04.9 Floor of mouth, unspecified	0.002	0.998	0.000
C04.0 Anterior floor of mouth	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.000	0.998	0.002
L50.8 Other urticaria	0.002	0.998	0.000
L50.6 Contact urticaria	0.002	0.998	0.000
L50.5 Cholinergic urticaria	0.002	0.998	0.000
L50.4 Vibratory urticaria	0.002	0.998	0.000
L50.3 Dermatographic urticaria	0.002	0.998	0.000
L50.2 Urticaria due to cold and heat	0.002	0.998	0.000
L73.2 Hidradenitis suppurativa	0.002	0.998	0.000
M62.9 Disorder of muscle, unspecified	0.002	0.998	0.000
M62.4 Contracture of muscle	0.002	0.998	0.000
M62.3 Immobility syndrome (paraplegic)	0.002	0.998	0.000
M62.2 Ischaemic infarction of muscle	0.002	0.998	0.000
M62.1 Other rupture of muscle (nontraumatic)	0.002	0.998	0.000
M62.58 Muscle wasting and atrophy, not elsewhere classified (Other)	0.002	0.998	0.000
M62.57 Muscle wasting and atrophy, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
M62.54 Muscle wasting and atrophy, not elsewhere classified (Hand)	0.002	0.998	0.000
M62.53 Muscle wasting and atrophy, not elsewhere classified (Forearm)	0.002	0.998	0.000
M62.52 Muscle wasting and atrophy, not elsewhere classified (Upper arm)	0.002	0.998	0.000
M62.51 Muscle wasting and atrophy, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
C00.9 Lip, unspecified	0.002	0.998	0.000
C05.9 Palate, unspecified	0.002	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
C00.8 Overlapping lesion of lip	0.002	0.998	0.000
C00.6 Commissure of lip	0.002	0.998	0.000
C00.5 Lip, unspecified, inner aspect	0.002	0.998	0.000
C00.4 Lower lip, inner aspect	0.002	0.998	0.000
C00.3 Upper lip, inner aspect	0.002	0.998	0.000
C00.2 External lip, unspecified	0.002	0.998	0.000
C00.1 External lower lip	0.002	0.998	0.000
C04.8 Overlapping lesion of floor of mouth	0.002	0.998	0.000
C04.1 Lateral floor of mouth	0.002	0.998	0.000
C13.9 Hypopharynx, unspecified	0.002	0.998	0.000
C13.8 Overlapping lesion of hypopharynx	0.002	0.998	0.000
C13.2 Posterior wall of hypopharynx	0.002	0.998	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.002	0.998	0.000
L53.3 Other chronic figurate erythema	0.002	0.998	0.000
L53.2 Erythema marginatum	0.002	0.998	0.000
L53.1 Erythema annulare centrifugum	0.002	0.998	0.000
C03.9 Gum, unspecified	0.002	0.998	0.000
C03.0 Upper gum	0.002	0.998	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.000	0.998	0.002
D75.0 Familial erythrocytosis	0.000	0.998	0.002
C10 Malignant neoplasm of oropharynx	0.002	0.998	0.000
Q80-Q89 Other congenital malformations	0.002	0.998	0.000
M62.66 Muscle strain (Lower leg)	0.002	0.998	0.000
M62.86 Other specified disorders of muscle (Lower leg)	0.002	0.998	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.000	0.998	0.002
C06.9 Mouth, unspecified	0.002	0.998	0.000
Q85.9 Phakomatosis, unspecified	0.002	0.998	0.000
L73 Other follicular disorders	0.002	0.998	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.002	0.998	0.000
C08.9 Major salivary gland, unspecified	0.002	0.998	0.000
C08.8 Overlapping lesion of major salivary glands	0.002	0.998	0.000
C08.1 Sublingual gland	0.002	0.998	0.000
C08.0 Submandibular gland	0.002	0.998	0.000
C06.2 Retromolar area	0.002	0.998	0.000
Q43 Other congenital malformations of intestine	0.002	0.998	0.000
Q61 Cystic kidney disease	0.002	0.998	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.002	0.998	0.000
C06.1 Vestibule of mouth	0.002	0.998	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.998	0.002
Q61.9 Cystic kidney disease, unspecified	0.002	0.998	0.000
Q61.5 Medullary cystic kidney	0.002	0.998	0.000
Q61.3 Polycystic kidney, unspecified	0.002	0.998	0.000
Q60-Q64 Congenital malformations of the urinary system	0.002	0.998	0.000
A49.8 Other bacterial infections of unspecified site	0.002	0.998	0.000
C11.8 Overlapping lesion of nasopharynx	0.002	0.998	0.000
C11.3 Anterior wall of nasopharynx	0.002	0.998	0.000
C11.2 Lateral wall of nasopharynx	0.002	0.998	0.000
C11.1 Posterior wall of nasopharynx	0.002	0.998	0.000
C11.0 Superior wall of nasopharynx	0.002	0.998	0.000
D47.2 Monoclonal gammopathy	0.000	0.998	0.002
Q63.1 Lobulated, fused and horseshoe kidney	0.002	0.998	0.000
R40.0 Somnolence	0.002	0.998	0.000
M62.08 Diastasis of muscle (Other)	0.002	0.998	0.000
K65.9 Peritonitis, unspecified	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
D22.5 Melanocytic naevi of trunk	0.002	0.998	0.000
L73.1 Pseudofolliculitis barbae	0.002	0.998	0.000
Q38.8 Other congenital malformations of pharynx	0.002	0.998	0.000
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
Q38.5 Congenital malformations of palate, not elsewhere classified	0.002	0.998	0.000
Q38.4 Congenital malformations of salivary glands and ducts	0.002	0.998	0.000
Q38.3 Other congenital malformations of tongue	0.002	0.998	0.000
Q38.2 Macroglossia	0.002	0.998	0.000
Q38.1 Ankyloglossia	0.002	0.998	0.000
Q38.0 Congenital malformations of lips, not elsewhere classified	0.002	0.998	0.000
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.002	0.998	0.000
M62.69 Muscle strain (Site unspecified)	0.002	0.998	0.000
M62.68 Muscle strain (Other)	0.002	0.998	0.000
M62.67 Muscle strain (Ankle and foot)	0.002	0.998	0.000
M62.65 Muscle strain (Pelvic region and thigh)	0.002	0.998	0.000
M62.64 Muscle strain (Hand)	0.002	0.998	0.000
M62.63 Muscle strain (Forearm)	0.002	0.998	0.000
M62.62 Muscle strain (Upper arm)	0.002	0.998	0.000
M62.61 Muscle strain (Shoulder region)	0.002	0.998	0.000
M62.60 Muscle strain (Multiple sites)	0.002	0.998	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.002	0.998	0.000
C14.2 Waldeyer's ring	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.002	0.998	0.000
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
L53.8 Other specified erythematous conditions	0.002	0.998	0.000
Q85.1 Tuberous sclerosis	0.002	0.998	0.000
Q40 Other congenital malformations of upper alimentary tract	0.002	0.998	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.002	0.998	0.000
M62.09 Diastasis of muscle (Site unspecified)	0.002	0.998	0.000
M62.07 Diastasis of muscle (Ankle and foot)	0.002	0.998	0.000
M62.06 Diastasis of muscle (Lower leg)	0.002	0.998	0.000
M62.05 Diastasis of muscle (Pelvic region and thigh)	0.002	0.998	0.000
M62.04 Diastasis of muscle (Hand)	0.002	0.998	0.000
M62.03 Diastasis of muscle (Forearm)	0.002	0.998	0.000
M62.02 Diastasis of muscle (Upper arm)	0.002	0.998	0.000
M62.01 Diastasis of muscle (Shoulder region)	0.002	0.998	0.000
M62.00 Diastasis of muscle (Multiple sites)	0.002	0.998	0.000
C06.0 Cheek mucosa	0.002	0.998	0.000
C79.2 Secondary malignant neoplasm of skin	0.000	0.998	0.002
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.998	0.002
K57.1 Diverticular disease of small intestine without perforation or abscess	0.000	0.998	0.002
Q89.9 Congenital malformation, unspecified	0.002	0.998	0.000
Q89.8 Other specified congenital malformations	0.002	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q89.4 Conjoined twins	0.002	0.998	0.000
Q89.3 Situs inversus	0.002	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.002	0.998	0.000
Q89.0 Congenital malformations of spleen	0.002	0.998	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.002	0.998	0.000
Z73.8 Other problems related to life-management difficulty	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
Q43.8 Other specified congenital malformations of intestine	0.002	0.998	0.000
Q43.3 Congenital malformations of intestinal fixation	0.002	0.998	0.000
Q43.1 Hirschsprung's disease	0.002	0.998	0.000
Q83 Congenital malformations of breast	0.002	0.998	0.000
M62.29 Ischaemic infarction of muscle (Site unspecified)	0.001	0.998	0.000
M62.28 Ischaemic infarction of muscle (Other)	0.001	0.998	0.000
M62.27 Ischaemic infarction of muscle (Ankle and foot)	0.001	0.998	0.000
M62.26 Ischaemic infarction of muscle (Lower leg)	0.001	0.998	0.000
M62.25 Ischaemic infarction of muscle (Pelvic region and thigh)	0.001	0.998	0.000
M62.24 Ischaemic infarction of muscle (Hand)	0.001	0.998	0.000
M62.23 Ischaemic infarction of muscle (Forearm)	0.001	0.998	0.000
M62.22 Ischaemic infarction of muscle (Upper arm)	0.001	0.998	0.000
M62.21 Ischaemic infarction of muscle (Shoulder region)	0.001	0.998	0.000
M62.20 Ischaemic infarction of muscle (Multiple sites)	0.001	0.998	0.000
M62.39 Immobility syndrome (paraplegic) (Site unspecified)	0.001	0.998	0.000
M62.38 Immobility syndrome (paraplegic) (Other)	0.001	0.998	0.000
M62.37 Immobility syndrome (paraplegic) (Ankle and foot)	0.001	0.998	0.000
M62.36 Immobility syndrome (paraplegic) (Lower leg)	0.001	0.998	0.000
M62.35 Immobility syndrome (paraplegic) (Pelvic region and thigh)	0.001	0.998	0.000
M62.34 Immobility syndrome (paraplegic) (Hand)	0.001	0.998	0.000
M62.33 Immobility syndrome (paraplegic) (Forearm)	0.001	0.998	0.000
M62.32 Immobility syndrome (paraplegic) (Upper arm)	0.001	0.998	0.000
M62.31 Immobility syndrome (paraplegic) (Shoulder region)	0.001	0.998	0.000
M62.30 Immobility syndrome (paraplegic) (Multiple sites)	0.001	0.998	0.000
M62.49 Contracture of muscle (Site unspecified)	0.001	0.998	0.000
M62.48 Contracture of muscle (Other)	0.001	0.998	0.000
M62.47 Contracture of muscle (Ankle and foot)	0.001	0.998	0.000
M62.46 Contracture of muscle (Lower leg)	0.001	0.998	0.000
M62.45 Contracture of muscle (Pelvic region and thigh)	0.001	0.998	0.000
M62.44 Contracture of muscle (Hand)	0.001	0.998	0.000
M62.43 Contracture of muscle (Forearm)	0.001	0.998	0.000
M62.42 Contracture of muscle (Upper arm)	0.001	0.998	0.000
M62.41 Contracture of muscle (Shoulder region)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations